C

Contec Medical Systems Co Ltd
SZSE:300869

Watchlist Manager
Contec Medical Systems Co Ltd
SZSE:300869
Watchlist
Price: 12.91 CNY Market Closed
Market Cap: ¥5.2B

Contec Medical Systems Co Ltd
Investor Relations

Contec Medical Systems makes medical devices that help doctors and patients measure and monitor health. Its product line includes patient monitors, ECG machines, pulse oximeters, blood pressure devices, ultrasound and other diagnostic equipment, plus home-care devices such as nebulizers and thermometers. The company sells these products to hospitals, clinics, distributors, and individual users in China and overseas. It makes money mainly by selling finished devices and related accessories. In practice, Contec sits in the middle of the healthcare supply chain: it designs and manufactures equipment, then ships it through direct sales, distributors, and export channels. That gives it exposure to both professional medical settings and lower-cost home health use. What makes its business different is the mix of clinical and household products. Some medical device makers focus only on high-end hospital systems, while Contec also serves the mass market with simpler monitoring tools that people can use at home. That broader product range helps it reach a wider customer base and rely on repeat purchases of devices and replacement parts.

Show more
Loading...
300869
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yang Zhishan
GM & Director
No Bio Available
Ms. Min Zheng
Deputy GM, Director, Financial Director & Board Secretary
No Bio Available
Mr. Yunlong Xu
Deputy General Manager
No Bio Available

Contacts

Address
HEBEI
Qinhuangdao
112 Qinhuang West Street, Economical Technology Development Zone
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett